Status:
TERMINATED
Tributyrin: Time Course & Efficacy to Improve Health & Performance
Lead Sponsor:
Florida State University
Collaborating Sponsors:
Compound Solutions Inc.
Conditions:
Metabolite Concentration
Gut Permeability
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would furth...
Eligibility Criteria
Inclusion
- Age: 30-50 years
- Sedentary (\<150 minutes of aerobic exercise per week)
Exclusion
- Chronic, uncontrolled metabolic, cardiovascular, gastrointestinal, or hepatic disease
- Consumption of supplements known to impact the microbiome, hydration status, core temperature, or exercise performance
- Experienced previous heat illness
- Known injuries that limit exercise
- BMI ≥ 40 kg/m\^2
- Pregnant
Key Trial Info
Start Date :
August 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT06501898
Start Date
August 19 2024
End Date
March 1 2025
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Sports Sciences & Medicine
Tallahassee, Florida, United States, 32301